Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial

Circulation

Volumn 89, Issue 4, 1994, Pages 1545-1556

  Braunwald, Eugene ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

angina; myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; DILTIAZEM; HEPARIN; ISOSORBIDE DINITRATE; METOPROLOL; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING; UNSTABLE ANGINA PECTORIS;

EID: 0028349701     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.89.4.1545     Document Type: Article

References (63)

1. Graves EJ. Detailed diagnoses and procedures. National Hospital Discharge Survey, 1990. National Center for Health Statistics. Vital Health Statistics. 1992;13(113).
2. Willerson JT, Campbell WB, Winniford MD, Schmilz J, Apprill P, Firth BG, Ashton J, Smitherman T, Bush L, Buja LM. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. Am J Cardiol. 1984;54:1349-1354.
3. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia predicts infarction and death during 2-year follow-up of unstable angina. J Am Coll Cardiol. 1987;10:756-760.
4. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250, 310-318.
5. De Wood MA, Stifter WF, Simpson CS, Spores J, Eugster GS, Judge TP, Hinnen ML. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med. 1986;315: 417-423.
6. Ambrose JA, Hjemdahl-Mouser CE, Borrico S, Gorlin R, Fuster V. Angiographic demonstration of a common link between unstable angina pectoris and non-Q-wave myocardial infarction. Am J Cardiol. 1988;61:244-247.
7. Theroux P, Outmet H, McCans J, LaTour JG, Joly P, Levy G, Pelletier E, Juneau M, Stasiak J, deGuise P, Pelletier GB, Rinzler D, Waters DD. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105-1111.
8. The TIMI IIIA Investigators. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit lesion in patients presenting with ischemic cardiac pain at rest: results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation. 1993;87:38-52.
9. Stone P, Kleiman N, Kronenberg M, Willerson J, Williams M, Prior MJ, Thompson B, Braunwald E, TIMI 3R Study Group. Effect of gender, race and age on the natural history of unstable angina and non-Q-wave MI: the T3 Registry. J Am Coll Cardiol. 1993;21:453A. Abstract.
10. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. N Engl J Med. 1989;320:618-627.
11. Campeau L. Grading of angina pectoris. Circulation. 1975;54: 522-523.
12. Fletcher GF, Froehlicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards: a statement for health professionals from the American Heart Association. Circulation. 1990;82:2286-2322.
13. Davies MJ, Thomas A. Plaque fissuring-the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
14. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction or sudden death. Circulation. 1985;71:699-708.
15. Sherman CT, Litvack F, Grundfest T, Lee M, Hickey A, Chaux A, Kass R, Blanche C, Matloff J, Morgenstern L, Ganz W, Swan HJC, Forrester J. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med. 1986;315:913-919.
16. Uchida Y, Fujimori Y, Hirose J, Oshima T. Percutaneous coronary angioscopy. Jpn Heart J. 1992;33:271-294.
17. Mizuno K, Satumora K, Miyamoto A, Arakawa E, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose J. Angioscopic evaluation of coronary artery thrombi in acute coronary syndromes. N Engl J Med. 1992;326:287-291.
18. Brunelli C, Spallarossa P, Ghigliotta G, Ianetti M, Caponnetto S. Thrombolysis in refractory unstable angina. Am J Cardiol. 1991;68: 110B-118B.
19. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988;77:1213-1220.
20. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983-989.
21. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981;304:685-691.
22. van den Berg EK, Schmitz JM, Benedict CR, Malloy CR, Willerson JT, Dehmer GJ. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation. 1989;79:116-124.
23. Willerson JT, Golino P, Eidt J, Campbell WB, Buja M. Platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80: 198-205.
24. Theroux P, Latour JF, Leger C, DeLara J. Fibrinopeptide A and platelet factor four levels in unstable angina pectoris. Circulation. 1987;75:156-162.
25. Alexopoulos D, Ambrose JA, Stump D, Borneo S, Gorlin R, Deshmukh P, Fisher EA. Thrombosis-related markers in unstable angina pectoris. J Am Coll Cardiol. 1991;17:866-871.
26. Bar FW, Verbeugt FW, Col J, Materne P, Monassier JP, Geslin PG, Metzger J, Raynaud P, Foucault J, de Zwaan C, Vermeer F. Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome: results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation. 1992;86:131-137.
27. Nicklas JM, Topol EJ, Kander N, O'Neill WW, Walton JA, Ellis SG, Gorman L, Pitt B. Randomized, double-blind, placebocontrolled trial of tissue plasminogen activator in unstable angina. J Am Coll Cardiol. 1989;13:434-441.
28. Freeman MR, Langer A, Wilson RF, Morgan CD, Armstrong PW. Thrombolysis in unstable angina: randomized double-blind trial of t-PA and placebo. Circulation. 1992;85:150-157.
29. Lawrence JR, Shepherd JT, Bone I, Rogen AS, Fulton WFM. Fibrinolytic therapy in unstable angina pectoris, a controlled clinical trial. Thromb Res. 1980;17:767-777.
30. Gold HK, Johns JA, Leinbach RC, Yasuda T, Grossbard E, Zusman R, Collen D. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris. Circulation. 1987;75: 1192-1199.
31. Mont L, Betriu A, Azqueta M, Sanz G. Early angiography and thrombolysis in patients with unstable angina. Circulation. 1988; 78(suppl II):II-420. Abstract.
32. Saran RK, Bhandari K, Narani VS, Ahuja RE, Puri VK, Thakur N, Dwivedi S, Hasan M. Intravenous streptokinase in a subset of patients with unstable angina: a randomized control trial. Int J Cardiol. 1990;28:209-213.
33. Schreiber TL, Rizik D, White C, Sharma GVRK, Cowley M, Macina G, Reddy PS, Kantounis L, Timmis GC, Margulis A, Bunnel P, Barker W, Sasahara A. Randomized trial of thrombolysis versus heparin in unstable angina. Circulation. 1992;86: 1407-1414.
34. Neri Serneri GG, Gensini GF, Poggesi L, Trotta F, Modesti PA, Boddi M, Ieri A, Margheri M, Casolo GC, Bini M, Rostagno C, Carnovali M, Abbate R. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischemia in refractory unstable angina. Lancet. 1990;335:615-618.
35. Stefenino G, Di Leo M, Bergerone S, Orzon F, Spinnler MT, Bonzano A, Brusea A. No benefit from infusion of intracoronary streptokinase in unstable angina: a prospective randomized trial. Eur Heart J. 1990;II:387. Abstract.
36. Waters D, Lam JYT. Is thrombolytic therapy striking out in unstable angina? Circulation. 1992;86:1642-1644.
37. Gruppo Italiana per Io Studio della Streptochinasi nell Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986; 1:349-360.
38. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
39. Eisenberg PR, Sherman LA, Jaffe AS. Paradoxic elevation of fibrin peptide A after streptokinase: evidence for intense thrombosis despite intense fibrinolysis. J Am Coll Cardiol. 1987;10:527-529.
40. Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER. Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. Blood. 1988;72:616-620.
41. Eisenberg PR, Sobel BS, Jaffe AS. Activation of prothrombin accompanying thrombolysis with recombinant tissue type plasminogen activator. J Am Coll Cardiol. 1992;19:1065-1069.
42. Lee C, Mann KG. The activation/inactivation of human factor V by plasmin. Blood. 1989;73:185-190.
43. 2+ mobilization and protein kinase C activation. J Clin Invest. 1993;91:547-552.
44. Noda-Heiny H, Fujii S, Sobel BE. Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin. Circ Res. 1993;72:36-43.
45. Rapold HJ. Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulation. Lancet. 1990;1: 481-482.
46. Eisenberg PR, Miletich JP. Induction of marked thrombin activity by pharmacologic concentrations of plasminogen activators in nonanticoagulated whole blood. Thromb Res. 1990;55:635-643.
47. Aronson DL, Chang P, Kessler GM. Platelet-dependent thrombin generation after in vitro fibrinolytic treatment. Circulation. 1992; 85:1706-1712,
48. Fitzgerald DJ, Catella F, Roy L, Fitzgerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988;77:142-150.
49. Kroll MH, Hellums JD, Guo Z, Durante W, Razdan K, Hrbolich TK, Schafer AI. Protein kinase C is activated in platelets subjected to pathologic shear stress. J Biol Chem. 1993;268:3250-3254.
50. Jang I-K, Gold HK, Ziskind AA, Fallon JT, Holt RE, Leinbach RC, May JW, Collen D. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation for resistance to coronary thrombolysis. Circulation. 1989;79:920-928.
51. Gold HK, Yasuda T, Jang IK, Guerrero JL, Fallon JT, Leinbach RC, Collen D. Animal models for arterial thrombolysis and prevention of reocclusion - erythrocyte-rich versus platelet-rich thrombus. Circulation. 1991;83(suppl IV):IV-26-IV-40.
52. Parise P, Agnelli G. Thrombus resistance to lysis and reocclusion: the role of platelets. Blood Coagul Fibrinolysis. 1991;2:749-758.
53. Ambrose JA, Torre SR, Sharma SK, Israel DH, Monsen CE, Weiss M, Untereker W, Grunwald A, Moses J, Marshall J, Bunell P, Sobolski J. Adjunctive thrombolytic therapy for angioplasty in ischemic rest angina: results of a double-blind randomized pilot study. J Am Coll Cardiol. 1992;20:1197-1204.
54. Weriz JI, Hudoba D, Massel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest. 1990;86:385-391.
55. Eisenberg PR, Siegel JE, Abendenschein DR, Miletich JP. Importance of factor Xa in determining the procoagulant activity of whole blood clots. J Clin Invest. 1993;91:1877-1803.
56. Markwardt F. Past, present and future of hirudin. Haemostasis. 1991;21(suppl 1):11-26.
57. Maraganore JM. Preclinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitor. In: Claeson G, Scully MF, Kakkar VV, Deadman J, eds. Design of Synthetic Inhibitors of Thrombin. New York, NY: Plenum Press; 1993:227-236.
58. Coller BS, Folts JD, Smith SR, Scudder LE, Jordan R. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor: correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors. Circulation. 1989;80:1766-1774.
59. Unstable Angina Pectoris Study Group. Unstable angina pectoris national cooperative study group to compare surgical and medical therapy, II: in-hospital experience and initial follow-up results in patients with one, two and three vessel disease. Am J Cardiol. 1978;42:839-848.
60. Cooperative Unstable Angina Study Group. Unstable angina pectoris: National Cooperative Study Group to compare medical and surgical therapy, III: results in patients with S-T segment elevation during pain. Am J Cardiol. 1980;45:819-824.
61. Luchi RJ, Scott SM, Deupree RH, Unstable Angina Study Principal Investigators and Associates. Comparison of medical and surgical treatment for unstable angina pectoris. N Engl J Med. 1987;316:977-984.
62. Parisi AF, Khuri S, Deupree RH, Sharma GVRK, Scott SM, Luchi RJ. Medical compared with surgical management of unstable angina 5-year mortality and morbidity in the Veterans Administration study. Circulation. 1989;80:1176-1189.
63. Passamani E, Davis KB, Gillespie MJ, Killip T, CASS Principal Investigators and Associates. A randomized trial of coronary bypass surgery: survival of patients with a low ejection fraction. N Engl J Med. 1985;312:1665-1671.